Emergent BioSolutions Inc (NYSE:EBS)
| 3.29 Delayed Data As of Sep 27 |  -0.015 / -0.45%Today’s Change | 3.08 Today|||52-Week Range 21.88 | -72.18% Year-to-Date |
Institutional investors purchased a net $1.5 million shares of EBS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 92.78% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 48.76% |
| Mutual fund holders | 44.02% |
| Individual stakeholders | 26.12% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 8/30/2023 | MILLENNIUM MANAGEMENT LLC Bought 1.4 Million shares of Emergent BioSolutions Inc |
| 6/30/2023 | SSGA FUNDS MANAGEMENT, INC. Bought 1.4 Million shares of Emergent BioSolutions Inc |
| 6/30/2023 | PRESCOTT GROUP CAPITAL MANAGEMEN... Bought 306.8 Thousand shares of Emergent BioSolutions Inc |
Top 10 Owners of Emergent BioSolutions Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 15.26% | 7,904,294 | 37,071,139 | +15,972 | +0.20% |
| SSgA Funds Management, Inc. | 13.11% | 6,794,144 | 31,864,535 | +1,388,594 | +25.69% |
| The Vanguard Group, Inc. | 8.25% | 4,272,712 | 20,039,019 | -1,053,057 | -19.77% |
| Millennium Management LLC | 5.23% | 2,711,399 | 12,716,461 | +1,429,125 | +111.45% |
| Dimensional Fund Advisors LP | 2.88% | 1,489,585 | 6,986,154 | -321,344 | -17.74% |
| Jacobs Levy Equity Management, In... | 2.38% | 1,234,447 | 5,789,556 | -9,335 | -0.75% |
| Hotchkis & Wiley Capital Manageme... | 2.19% | 1,134,420 | 5,320,430 | +190,760 | +20.21% |
| Charles Schwab Investment Managem... | 2.08% | 1,078,418 | 5,057,780 | +257,198 | +31.32% |
| D. E. Shaw & Co. LP | 1.89% | 977,917 | 4,586,431 | -385,863 | -28.29% |
| Geode Capital Management LLC | 1.78% | 924,484 | 4,335,830 | +28,030 | +3.13% |
Top 10 Mutual Funds Holding Emergent BioSolutions Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 9.69% | 5,021,384 | 23,550,291 | +70,907 | +1.43% |
| Vanguard Total Stock Market ETF | 2.79% | 1,443,279 | 6,768,979 | 0 | 0.00% |
| iShares Russell 2000 ETF | 2.22% | 1,148,039 | 5,384,303 | -1,616 | -0.14% |
| Vanguard Extended Market Index Fu... | 1.23% | 636,518 | 2,985,269 | +585 | +0.09% |
| Stichting Pensioenfonds ABP (Glob... | 1.22% | 632,578 | 2,966,791 | +632,578 | -- |
| Direxion Daily S&P Biotech Bull 3... | 1.19% | 616,228 | 2,890,109 | 0 | 0.00% |
| Bridgeway Small Cap Value Fund | 1.15% | 593,733 | 2,784,608 | 0 | 0.00% |
| Vanguard Small Cap Index Fund | 1.14% | 589,713 | 2,765,754 | +1,632 | +0.28% |
| Schwab Fundamental US Small Compa... | 1.10% | 569,444 | 2,670,692 | 0 | 0.00% |
| BlackRock Advantage Small Cap Cor... | 1.05% | 546,090 | 2,561,162 | +154,088 | +39.31% |